La chimiothérapie métronomique du cancer du sein métastatique: à propos d'un cas = Metronomic chemotherapy for metastatic breast cancer: a case studyGAUMIER, A; HAMIZI, S; YOU, B et al.Oncologie (Paris). 2010, Vol 12, Num 7, pp 436-439, issn 1292-3818, 4 p.Article

Chimiothérapie métronomique en 2011: actualités et perspectives = Metronomic chemotherapy in 2011: update and perspectivesBENBRAHIM, Zineb; MASSARD, Christophe; EL MESBAHI, Omar et al.Bulletin du cancer. 2011, Vol 98, Num 12, pp 1447-1454, issn 0007-4551, 8 p.Article

Influence of formulation vehicle on metronomic taxane chemotherapy : Albumin-bound versus cremophor EL - based paclitaxelNG, Sylvia S. W; SPARREBOOM, Alex; SHAKED, Yuval et al.Clinical cancer research. 2006, Vol 12, Num 14, pp 4331-4338, issn 1078-0432, 8 p., 1Article

Metronomic chemotherapy for cancer treatment: a decade of clinical studiesROMITI, Adriana; COX, M. Christina; SARCINA, Ida et al.Cancer chemotherapy and pharmacology. 2013, Vol 72, Num 1, pp 13-33, issn 0344-5704, 21 p.Article

The anti-tumour effect of low-dose continuous chemotherapy may partly be mediated by thrombospondinDAMBER, Jan-Erik; VALLBO, Christina; ALBERTSSON, Per et al.Cancer chemotherapy and pharmacology. 2006, Vol 58, Num 3, pp 354-360, issn 0344-5704, 7 p.Article

L'immunothérapie: une nouvelle approche dans La prise en charge du cancer de prostate résistant à la castration = Immunotherapy: an emerging strategies against prostate castration resistant cancerMANSI, Laura; THIERY-VUILLEMIN, Antoine; ADOTEVI, Olivier et al.Bulletin du cancer. 2012, Vol 99, issn 0007-4551, S57-S65, SUP1Article

Effective Treatment of Advanced Human Melanoma Metastasis in Immunodeficient Mice Using Combination Metronomic Chemotherapy RegimensCRUZ-MUNOZ, William; SHAN MAN; KERBEL, Robert S et al.Clinical cancer research (Print). 2009, Vol 15, Num 15, pp 4867-4874, issn 1078-0432, 8 p.Article

Metronomic chemotherapy in advanced soft tissue sarcomasITALIANO, Antoine; TOULMONDE, Maud; LORTAL, Barbara et al.Cancer chemotherapy and pharmacology. 2010, Vol 66, Num 1, pp 197-202, issn 0344-5704, 6 p.Article

Chimiothérapie métronomique en oncologie pédiatrique: effet de mode ou espoir réel ? = Metronomic chemotherapy in pediatric oncology: Hype or hope?ANDRE, N; PASQUIER, E; VERSCHUUR, A et al.Archives de pédiatrie (Paris). 2009, Vol 16, Num 8, pp 1158-1165, issn 0929-693X, 8 p.Article

Low-dose metronomic chemotherapy: A systematic literature analysisLIEN, K; GEORGSDOTTIR, S; SIVANATHAN, L et al.European journal of cancer (1990). 2013, Vol 49, Num 16, pp 3387-3395, issn 0959-8049, 9 p.Article

Cyclophosphamide-based metronomic chemotherapy: After 10 years of experience, where do we stand and where are we going?PENEL, Nicolas; ADENIS, Antoine; BOCCI, Guido et al.Critical reviews in oncology/hematology. 2012, Vol 82, Num 1, pp 40-50, issn 1040-8428, 11 p.Article

Metronomic chemotherapy enhances the efficacy of antivascular therapy in ovarian cancerKAMAT, Aparna A; TAE JIN KIM; HEYMACH, John V et al.Cancer research (Baltimore). 2007, Vol 67, Num 1, pp 281-288, issn 0008-5472, 8 p.Article

The Immune Response and the Therapeutic Effect of Metronomic Chemotherapy With CyclophosphamideROZADOS, Viviana R; MAINETTI, Leandro E; RICO, María J et al.Oncology research. 2010, Vol 18, Num 11-12, pp 601-605, issn 0965-0407, 5 p.Article

Metronomic chemotherapy following the maximum tolerated dose is an effective anti-tumour therapy affecting angiogenesis, tumour dissemination and cancer stem cellsVIVES, Marta; GINESTA, Mireia M; GRACOVA, Kristina et al.International journal of cancer (Print). 2013, Vol 133, Num 10, pp 2464-2472, issn 0020-7136, 9 p.Article

Metronomic Chemotherapy for Metastatic Prostate Cancer: A 'Young' Concept for Old Patients?FONTANA, Andrea; FALCONE, Alfredo; DEROSA, Lisa et al.Drugs & aging. 2010, Vol 27, Num 9, pp 689-696, issn 1170-229X, 8 p.Article

Metronomic doxifluridine chemotherapy combined with the anti-angiogenic agent TNP-470 inhibits the growth of human uterine carcinosarcoma xenograftsNAGANUMA, Yasuko; CHOIJAMTS, Batsuren; SHIROTA, Kyoko et al.Cancer science. 2011, Vol 102, Num 8, pp 1545-1552, issn 1347-9032, 8 p.Article

Therapeutic efficacy of metronomic chemotherapy with cyclophosphamide and doxorubicin on murine mammary adenocarcinomasMAINETTI, L. E; RICO, M. J; FERNANDEZ-ZENOBI, M. V et al.Annals of oncology. 2013, Vol 24, Num 9, pp 2310-2316, issn 0923-7534, 7 p.Article

Beneficial effect of metronomic chemotherapy on tumor suppression and survival in a rat model of hepatocellular carcinoma with liver cirrhosisSEONG TAE PARK; JEONG WON JANG; JONG YOUNG CHOI et al.Cancer chemotherapy and pharmacology. 2010, Vol 65, Num 6, pp 1029-1037, issn 0344-5704, 9 p.Article

Multiple tumor marker elevation in androgen ablation-refractory prostate cancer with long-term response to metronomic chemotherapy: a case reportMASSACCESI, Mariangela; FORNI, Franca; SPAGNUOLO, Pasquale et al.The International journal of biological markers. 2010, Vol 25, Num 4, pp 243-247, issn 0393-6155, 5 p.Article

Metronomic Etoposide/Cyclophosphamide/Celecoxib Regimen Given to Children and Adolescents with Refractory Cancer : A Preliminary Monocentric StudyANDRE, Nicolas; ROME, Angelique; COZE, Carole et al.Clinical therapeutics. 2008, Vol 30, Num 7, pp 1336-1340, issn 0149-2918, 5 p.Article

Bevacizumab in Combination with Metronomic Chemotherapy in Patients with Anthracycline-and Taxane-Refractory Breast CancerGARCIA-SAENZ, J. A; MARTIN, M; CALLES, A et al.Journal of chemotherapy (Testo stampato). 2008, Vol 20, Num 5, pp 632-639, issn 1120-009X, 8 p.Article

Metronomic docetaxel chemotherapy inhibits angiogenesis and tumor growth in a gastric cancer modelHONGJU WU; YAN XIN; JING ZHAO et al.Cancer chemotherapy and pharmacology. 2011, Vol 68, Num 4, pp 879-887, issn 0344-5704, 9 p.Article

Sorafenib enhances the in vitro anti-endothelial effects of low dose (metronomic) chemotherapyMURRAY, Alexandra; LITTLE, Samantha J; STANLEY, Paul et al.Oncology reports. 2010, Vol 24, Num 4, pp 1049-1058, issn 1021-335X, 10 p.Article

On the development of models in mice of advanced visceral metastatic disease for anti-cancer drug testingSHAN MAN; MUNOZ, Raquel; KERBEL, Robert S et al.Cancer metastasis reviews. 2007, Vol 26, Num 3-4, pp 737-747, issn 0167-7659, 11 p.Article

Angiogenesis and cancer: A cross-talk between basic science and clinical trials (the do ut des paradigm)DE CASTRO JUNIOR, Gilberto; PUGLISI, Fabio; DE AZAMBUJA, Evandro et al.Critical reviews in oncology/hematology. 2006, Vol 59, Num 1, pp 40-50, issn 1040-8428, 11 p.Article